These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24025544)

  • 1. Myocardin: new therapeutic agent in vascular disease?
    Long X; Miano JM
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2284-5. PubMed ID: 24025544
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β.
    Talasila A; Yu H; Ackers-Johnson M; Bot M; van Berkel T; Bennett MR; Bot I; Sinha S
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2355-65. PubMed ID: 23825366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
    Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
    Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myb Regulates Proliferation and Differentiation of Adventitial Sca1+ Vascular Smooth Muscle Cell Progenitors by Transactivation of Myocardin.
    Shikatani EA; Chandy M; Besla R; Li CC; Momen A; El-Mounayri O; Robbins CS; Husain M
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1367-76. PubMed ID: 27174098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasomal degradation of myocardin is required for its transcriptional activity in vascular smooth muscle cells.
    Yin H; Jiang Y; Li H; Li J; Gui Y; Zheng XL
    J Cell Physiol; 2011 Jul; 226(7):1897-906. PubMed ID: 21506120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
    Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
    Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancer of polycomb1 lessens neointima formation by potentiation of myocardin-induced smooth muscle differentiation.
    Joung H; Kwon JS; Kim JR; Shin S; Kang W; Ahn Y; Kook H; Kee HJ
    Atherosclerosis; 2012 May; 222(1):84-91. PubMed ID: 22398275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.
    van der Veer EP; de Bruin RG; Kraaijeveld AO; de Vries MR; Bot I; Pera T; Segers FM; Trompet S; van Gils JM; Roeten MK; Beckers CM; van Santbrink PJ; Janssen A; van Solingen C; Swildens J; de Boer HC; Peters EA; Bijkerk R; Rousch M; Doop M; Kuiper J; Schalij MJ; van der Wal AC; Richard S; van Berkel TJ; Pickering JG; Hiemstra PS; Goumans MJ; Rabelink TJ; de Vries AA; Quax PH; Jukema JW; Biessen EA; van Zonneveld AJ
    Circ Res; 2013 Oct; 113(9):1065-75. PubMed ID: 23963726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic Factor With G Patch and FHA Domains 1 Is a Novel Regulator of Vascular Injury.
    Zhou B; Zeng S; Li N; Yu L; Yang G; Yang Y; Zhang X; Fang M; Xia J; Xu Y
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):675-684. PubMed ID: 28153879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of CXCR4(+)/PDGFRbeta(+) progenitor cells in hypoxic alveolar arterioles muscularization: role of myocardin.
    Jie W; Wang X; Huang L; Guo J; Kuang D; Zhu P; Li M; Zhao X; Duan Y; Wang G; Ao Q
    Cardiovasc Res; 2010 Sep; 87(4):740-50. PubMed ID: 20484220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease.
    Kiyan Y; Limbourg A; Kiyan R; Tkachuk S; Limbourg FP; Ovsianikov A; Chichkov BN; Haller H; Dumler I
    Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):110-22. PubMed ID: 22075245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation.
    Chen J; Yin H; Jiang Y; Radhakrishnan SK; Huang ZP; Li J; Shi Z; Kilsdonk EP; Gui Y; Wang DZ; Zheng XL
    Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):368-75. PubMed ID: 21051663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury.
    Xin M; Small EM; Sutherland LB; Qi X; McAnally J; Plato CF; Richardson JA; Bassel-Duby R; Olson EN
    Genes Dev; 2009 Sep; 23(18):2166-78. PubMed ID: 19720868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors.
    Hinson JS; Medlin MD; Lockman K; Taylor JM; Mack CP
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1170-80. PubMed ID: 16997888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a vascular smooth muscle-derived foam-cell really change its spots?
    Huff MW; Pickering JG
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):492-5. PubMed ID: 25717175
    [No Abstract]   [Full Text] [Related]  

  • 17. Apatinib attenuates phenotypic switching of arterial smooth muscle cells in vascular remodelling by targeting the PDGF Receptor-β.
    Shao W; Li X; Peng J; Fan S; Liang M; Huang K
    J Cell Mol Med; 2020 Sep; 24(17):10128-10139. PubMed ID: 32697395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
    Huang C; Zhang W; Zhu Y
    Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
    Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
    Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.